Influence of post-COVID-19 infection on the level of interleukin-17 in patients with ankylosing spondylitis

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/4938

Full metadata record

DC Field	Value	Language
dc.contributor.author	N.M. Abdurakhmanova, Kh.S. Ahmedov, F.S. Razzakova	-
dc.date.accessioned	2022-12-13T07:30:13Z	-
dc.date.available	2022-12-13T07:30:13Z	-
dc.date.issued	2022	-
dc.identifier.citation	Тошкент	en_US
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/4938	-
dc.description.abstract	The article presents data from our own studies devoted to the study of the level of pro-inflammatory cytokine - interleukin-17 in patients with ankylosing spondylitis in the post-covid period. The level of interleukin-17 was compared in two groups: in patients who were not ill and who underwent COVID-19, as well as in healthy individuals. The level of interleukin-17 was also compared with clinical symptoms and disease activity. According to the results of the research, the influence of coronavirus infection on the increase in the level of interleukin-17, as well as an increase in the activity of the disease in patients with ankylosing spondylitis was revealed.	en_US
dc.language.iso	other	en_US
dc.relation.ispartofseries	УДK;616.72-002.77-08	-
dc.subject	COVID-19, interleukin -17, ankylosing spondylitis, BASDAI, ASDAS.	en_US
dc.title	Influence of post-COVID-19 infection on the level of interleukin-17 in patients with ankylosing spondylitis	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
25. Инфекция, иммунитет 2022.pdf	Influence of post-COVID-19 infection on the level of interleukin-17 in patients with ankylosing spondylitis	2.54 MB	Adobe PDF	View/Open

DSpace JSPUI